Literature DB >> 10599936

Gabapentin leads to remission of somatoform pain disorder with major depression.

I Maurer1, H P Volz, H Sauer.   

Abstract

Gabapentin, a novel antiepileptic drug, is effective in the treatment of partial seizures with and without secondary generalization. Evidence suggests that it may have mood-stabilizing and possibly antidepressant properties in bipolar depression. We report on a 48-year-old woman who had recurrent major depressive disorder. Following inguinal herniorrhaphy, she developed severe stabbing pain in the lower abdomen and inguinal area that progressed to constant pain in her whole body. She was depressive, hopeless, and had given up her social activities. A diagnosis of major depressive disorder and somatoform pain disorder was made. Antidepressants and carbamazepine were ineffective, and she had attempted suicide. Gabapentin resulted in remission of both the pain and the depressive mood at a dose of 1.800 mg/day.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599936     DOI: 10.1055/s-1999-7958

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  6 in total

1.  Gabapentin and venlafaxine reduce pain in a patient with somatic symptom disorder.

Authors:  Shady S Shebak
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-31

2.  [Psychopharmacological treatment in patients with somatoform disorders and functional body syndromes].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

3.  Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Authors:  Barbara J Mason; John M Light; Lauren D Williams; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 4.  Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.

Authors:  Kathryn J Macdonald; L Trevor Young
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Authors:  Rachel K Berlin; Paul M Butler; Michael D Perloff
Journal:  Prim Care Companion CNS Disord       Date:  2015-10-22

Review 6.  Behavioural effects of the new anticonvulsants.

Authors:  F M Besag
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.